- Home
- GERN vs LMND Comparison
GERN vs LMND Comparison
Compare GERN & LMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- LMND
- Stock Information
- Founded
- GERN 1990
- LMND 2015
- Country
- GERN United States
- LMND United States
- Employees
- GERN N/A
- LMND N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- LMND Property-Casualty Insurers
- Sector
- GERN Health Care
- LMND Finance
- Exchange
- GERN Nasdaq
- LMND Nasdaq
- Market Cap
- GERN 2.5B
- LMND 2.5B
- IPO Year
- GERN 1996
- LMND 2020
- Fundamental
- Price
- GERN $2.89
- LMND $32.81
- Analyst Decision
- GERN Strong Buy
- LMND Hold
- Analyst Count
- GERN 10
- LMND 7
- Target Price
- GERN $7.15
- LMND $33.71
- AVG Volume (30 Days)
- GERN 14.8M
- LMND 2.1M
- Earning Date
- GERN 02-26-2025
- LMND 02-25-2025
- Dividend Yield
- GERN N/A
- LMND N/A
- EPS Growth
- GERN N/A
- LMND N/A
- EPS
- GERN N/A
- LMND N/A
- Revenue
- GERN $29,480,000.00
- LMND $492,500,000.00
- Revenue This Year
- GERN $31,478.06
- LMND N/A
- Revenue Next Year
- GERN $290.89
- LMND $26.83
- P/E Ratio
- GERN N/A
- LMND N/A
- Revenue Growth
- GERN 9199.68
- LMND 22.09
- 52 Week Low
- GERN $1.64
- LMND $14.03
- 52 Week High
- GERN $5.34
- LMND $53.85
- Technical
- Relative Strength Index (RSI)
- GERN 25.84
- LMND 40.66
- Support Level
- GERN $2.80
- LMND $30.05
- Resistance Level
- GERN $3.68
- LMND $33.75
- Average True Range (ATR)
- GERN 0.18
- LMND 2.41
- MACD
- GERN -0.04
- LMND -0.67
- Stochastic Oscillator
- GERN 10.23
- LMND 19.35
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.